Oncology

Resource Center

Featured

FDA Alert
FDA Alert
12/15/2025
Kate Young
An open-label, randomized trial found that daratumumab and hyaluronidase-fihj administered subcutaneously improved the risk of disease progression or death in patients with multiple myeloma. As a result,...
12/15/2025
CONFERENCE COVERAGE
CONFERENCE COVERAGE
12/12/2025
Anthony Calabro, MA
A large, real-world comparative analysis evaluated 1-year clinical and safety outcomes among patients with chronic lymphocytic leukemia receiving venetoclax-based versus Bruton's tyrosine kinase...
12/12/2025
Pop Quiz
Pop Quiz
12/09/2025
Anthony Calabro, MA
Ibrutinib, the first-generation Bruton tyrosine kinase inhibitor, has well-documented cardiovascular effects that influence treatment decisions for patients with chronic lymphocytic leukemia. This quiz...
12/09/2025

Interactive Features

Pop Quiz
Pop Quiz
12/09/2025
Anthony Calabro, MA
Ibrutinib, the first-generation Bruton tyrosine kinase inhibitor, has well-documented cardiovascular effects that influence treatment decisions for patients with chronic lymphocytic leukemia. This quiz...
12/09/2025
3-in-30
3-in-30
10/30/2025
Kate Young
According to research published in JAMA Surgery, missed opportunities for risk assessment and surgical prevention are common among ovarian cancer patients with high-grade serous cancer (HGSC). Take this...
10/30/2025
Slideshow
Slideshow
10/27/2025
Kate Young
October is Breast Cancer Awareness Month. Swipe through this slideshow to explore our latest coverage highlighting the evolving science shaping breast cancer care today from approaches to surgery and...
10/27/2025
Pop Quiz
Pop Quiz
10/14/2025
Miranda Manier, BA
Richter transformation of chronic lymphocytic leukemia carries poor outcomes with traditional therapies, but emerging treatments may improve survival. Test your knowledge of prognosis by taking this quick...
10/14/2025
3-in-30
3-in-30
10/13/2025
Kate Young
Male breast cancer comprises 0.3% of all cancer in men, but men typically present with more advanced disease than women due to delayed care. This quick quiz will test your knowledge on male breast cancer...
10/13/2025

Clinical Insights

Expert Q&A
Expert Q&A
11/04/2025
Daniel Lenihan, MD, FACC, FESC
Daniel Lenihan, MD, FACC, FESC, FIC-OS, a cardio-oncologist and founder of the International Cardio-Oncology Society, discusses cardiovascular risks associated with Bruton's tyrosine kinase inhibitors in...
11/04/2025
Video: Multidisciplinary Roundtable
Video: Multidisciplinary Roundtable
08/25/2025
Jaspal Singh, MD, MHA, MHS; Jasleen Pannu, MD; Coral Giovacchini, MD; Leisa Lackey
In this video roundtable discussion, Jaspal Singh, MD, MHA, MHS, interviews Jasleen Pannu, MD, Coral Giovacchini, MD, and Leisa Lackey about the design, growth, and importance of incidental lung nodule...
08/25/2025
Video
Video
07/08/2025
Karyn Goodman, MD, MS
In this video, Karyn A. Goodman, MD, MS, Professor and Vice Chair for Research and Quality in the Department of Radiation Oncology at the Icahn School of Medicine at Mount Sinai, provided insights into...
07/08/2025
Nutrition411, ep. 41
Nutrition411, ep. 41
05/05/2025
Lisa Jones, MA, RDN, LDN, FAND
In this podcast, Lisa Jones RDN, LDN speaks with Amy Bragagnini RD, CSO, a clinical oncology dietitian at Trinity Health Lacks Cancer Center in Grand Rapids, MI, about the commons myths involving diet and...
05/05/2025
Case Report Insights
Case Report Insights
04/02/2025
Nandini N. Patel, BS
In this Consultant Case Report Insights, Nandini N. Patel, OMS III, speak about her study, “Metastatic Malignant Melanoma from Unknown Origin to the Jejunum: A Case Report.” Nandini Patel discusses the...
04/02/2025